2024 Revenue Guidance: Raised to $16.1 billion to $16.5 billion. 2024 EPS Guidance: Raised to $2.40 to $2.50. Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported a 15% increase in revenues, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback